Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × INDUSTRY × molibresib × Clear all

Status

Terminated 1 No longer available 1 Completed 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumours 1

Interventions

dabrafenib 4 trametinib 3 nilotinib 3 midostaurin 3 elotuzumab 3 Nivolumab 3 talimogene laherparepvec 2 regorafenib 2 Suspensions 2 Prednisone 2 Powders 2 Panobinostat 2 Melphalan 2 Lenalidomide 2 Ipilimumab 2 Everolimus 2 Dexamethasone 2 Bortezomib 2 zanubrutinib 1 zanidatamab 1 venetoclax 1 veliparib 1 tucatinib 1 tazemetostat 1 taletrectinib 1 surufatinib 1 sugemalimab 1 selitrectinib 1 ruxolitinib 1 rovalpituzumab tesirine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03702036 2020-04-13

Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma

GlaxoSmithKline

No longer available

Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡